Acute Megakaryoblastic Leukemia Latest Advances
Find the Latest Research About Acute Megakaryoblastic Leukemia
Last Updated: 02/24/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1316 publications
NPM1-mutated acute myeloid leukemia with marked erythroid and megakaryocytic differentiation.
Journal: Blood
Published: November 20, 2025
Acute myeloid leukemia with bipotential erythroid and megakaryocytic differentiation: a case series and literature review.
Journal: Journal of hematopathology
Published: October 21, 2025
Regulation of cell cycle by the novel GATA1/TAL1/Sphingomyelin Synthase 1 ( SGMS1 ) transcriptional axis. Implications for anti-leukemic strategies.
Journal: bioRxiv : the preprint server for biology
Published: October 01, 2025
Stag2 dependent chromatin remodeling enforces the erythroid-specific Gata1 cistrome.
Journal: bioRxiv : the preprint server for biology
Published: September 26, 2025
A case report focusing on diagnosis and intervention of chronic myeloid leukemia in blast crisis (acute megakaryoblastic leukemia subtype).
Journal: Frontiers in oncology
Published: September 23, 2025
Non-Down-syndrome-related acute megakaryoblastic leukemia in children: a clinical analysis of 17 cases
Journal: Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
Published: September 17, 2025
BCR::ABL1-Positive Secondary B-Acute Lymphoblastic Leukemia Mimicking Acute Megakaryoblastic Leukemia Following Multiple Myeloma
Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology
Published: August 27, 2025
Megakaryocytic Emperipolesis in Acute Myeloid Leukemia with Trisomy 8
Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology
Published: August 27, 2025
Pediatric Acute Megakaryoblastic Leukemia with a GATA2 Mutation and Monosomy 7: A Case Report and Clinical Management Challenges.
Journal: Reports (MDPI)
Published: June 29, 2025
FUBP3 mediates MXI1 stability to silence RRAS and hinder MAPK signaling in acute megakaryoblastic leukemia progression.
Journal: Cancer immunology, immunotherapy : CII
Published: June 06, 2025
Last Updated: 02/24/2026